| Name | Title | Contact Details |
|---|
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
RX Staffing & Home Care is a Sacramento, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cosmaceutical Research is a Surrey, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
aaiPharma Inc. (aaiPharma) is a science-based pharmaceutical company offering pharmaceutical development capabilities primarily in the United States and Europe.
The CDM Group is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. The CDM Group is based in New York, NY. You can find more information on The CDM Group at www.thecdmgroup.com